VCNX vaccinex.com: Business Value

Vaccinex Inc (VCNX) - corporate logo

The Vaccinex, Inc. (VCNX) biotech business relies on trials of a unified antibody system targeting oncology and dementia, creating high risks prior to market entry. This price trend chart on GURU.Markets shows that the Enterprise Value is , with growth driven by pepinemab's success and partner payments. The team consists of clinician-scientists retained by stock options and the significance of their scientific research.

VCNX (Vaccinex, Inc.) Total Company Value history from 07/04/2022 to 10/29/2026

Vaccinex, Inc. - analytical breakdowns and key metrics (VCNX)

- price and consensus price forecast:
Stock Quotes Vaccinex Inc.|VCNX - Price Target Chart
- market capitalization data:
Market Capitalization Vaccinex|VCNX - Real Price to Acquire Entire Company
- book capitalization data:
Equity per Share Vaccinex|VCNX - Company Book Value|Market-to-Book Ratio vaccinex.com|VCNX - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity Ratio Vaccinex, Inc.|VCNX - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio vaccinex.com|VCNX - Company Debts|Debts to Book Value Vaccinex|VCNX - Company Long-Term Debt|Company Short-Term Debt Vaccinex
Fundamental valuation:Vaccinex Inc. (VCNX)
Original product of Vaccinex

Enterprise Value (EV) combines market capitalization with net debt, reflecting the actual cost of a full business buyout while accounting for liquid assets. By analyzing the current enterprise value, an investor can correlate the asset value of Vaccinex, Inc. (VCNX) with the capital intensity of implementing robotic antibody screening stations and automating the digitization of oncological data, which determines the company's fundamental stability.

Competitors of Vaccinex, Inc. (VCNX)

ImmunityBio Inc - Real Price to Acquire Entire Company|Immunocore PLC (IMCR) - Total Company Value|Janux Corp (JANX) - Business Value|Real Price to Acquire Entire Company Arcus Biosciences, Inc.|ZYME (zymeworks.com) - Business Value|Total Company Value TNGX (Tango Therapeutics, Inc.)|Total Enterprise Value IOVA|Total Company Value Immatics Corp IMTX|Business Value Xencor Inc. (XNCR)|Compass Therapeutics - Enterprise Value|replimune.com - Real Price to Acquire Entire Company|LYEL (Lyell Immunopharma, Inc.) - Total Company Value|IPHA: Total Enterprise Value|pyxisoncology.com (PYXS) - Total Company Value|CGEN (Compugen) - Total Company Value|Total Company Value IOBT (IO Biotech, Inc.)|Total Enterprise Value sutrobio.com|INKT: Enterprise Value|Full Takeover Company Value werewolftx.com HOWL|IMMX: Real Price to Acquire Entire Company|ALXO - Total Enterprise Value|Real Price to Acquire Entire Company Cue Biopharma, Inc. (CUE)|PDSB - Value Adjusted for Debt and Cash|sonnetbio.com - Enterprise Value|MAIA (MAIA Biotech) - Company Buyout Price|Total Company Value LIMN|Real Price to Acquire Entire Company LVTX|Total Company Value NXTC (NextCure, Inc.)|Real Price to Acquire Entire Company leaptx.com LPTX|Real Price to Acquire Entire Company INTS (Intensity Therapeutics, Inc.)|Sensei Biotherapeutics Inc - Enterprise Value|Synthetic Biologics (TOVX) - Total Company Value|GRTS: Business Value|Total Company Value KA|Total Enterprise Value neximmune.com|Turnstone Biologics Corp - Real Price to Acquire Entire Company|Full Takeover Company Value Harpoon Therapeutics Inc (HARP)